tiprankstipranks
Advertisement
Advertisement

VNRX Stock Latest News

VolitionRx Shareholders Approve Governance and Capital Changes
Company AnnouncementsVolitionRx Shareholders Approve Governance and Capital Changes
4d ago
8K
VNRX
VolitionRx registers to sell 3.31M shares of common stock for holders
PremiumThe Fly
VolitionRx registers to sell 3.31M shares of common stock for holders
15d ago
VNRX
VolitionRx announces data on prognostic value of Nu.Q Cancer Assay
PremiumThe Fly
VolitionRx announces data on prognostic value of Nu.Q Cancer Assay
18d ago
VNRX
VolitionRx Converts Debt to Equity Through Share Issuances
PremiumCompany Announcements
VolitionRx Converts Debt to Equity Through Share Issuances
1M ago
8K
VNRX
VolitionRx resumed with a Buy at Maxim
PremiumThe Fly
VolitionRx resumed with a Buy at Maxim
1M ago
VNRX
VolitionRx announces collaboration with Sysmex
PremiumThe FlyVolitionRx announces collaboration with Sysmex
1M ago
VNRX
VolitionRx files patent covering Nu.Q technology for Ebola triage
Premium
The Fly
VolitionRx files patent covering Nu.Q technology for Ebola triage
2M ago
VNRX
VolitionRx Secures Waiver on Convertible Note Covenant Breach
Premium
Company Announcements
VolitionRx Secures Waiver on Convertible Note Covenant Breach
2M ago
8K
VNRX
VolitionRX Earnings Call Balances Breakthroughs and Risks
PremiumCompany Announcements
VolitionRX Earnings Call Balances Breakthroughs and Risks
2M ago
VNRX
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
PremiumRatings
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
2M ago
VNRX
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
PremiumCompany Announcements
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
2M ago
VNRX
VolitionRx Announces Board Streamlining as Director Departs
PremiumCompany Announcements
VolitionRx Announces Board Streamlining as Director Departs
2M ago
8K
VNRX
VolitionRx reports Q1 revenue $1M, consensus $409,920
PremiumThe FlyVolitionRx reports Q1 revenue $1M, consensus $409,920
2M ago
VNRX
VolitionRx submits manuscript for Nu.Q Vet cancer test in cats
Premium
The Fly
VolitionRx submits manuscript for Nu.Q Vet cancer test in cats
3M ago
VNRX
VolitionRx announces milestone in nucleosomes detection
Premium
The Fly
VolitionRx announces milestone in nucleosomes detection
3M ago
VNRX
VolitionRx Enacts One-for-Twenty Reverse Stock Split
PremiumCompany Announcements
VolitionRx Enacts One-for-Twenty Reverse Stock Split
3M ago
8K
VNRX
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
3M ago
UP
OCG
VolitionRx’s compliance plan accepted by NYSE American
PremiumThe Fly
VolitionRx’s compliance plan accepted by NYSE American
3M ago
VNRX
VolitionRx downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
VolitionRx downgraded to Hold from Buy at D. Boral Capital
3M ago
VNRX
VolitionRx Sets One-for-Twenty Reverse Stock Split
PremiumCompany AnnouncementsVolitionRx Sets One-for-Twenty Reverse Stock Split
3M ago
8K
VNRX
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
Premium
Company Announcements
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
4M ago
VNRX
VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut
Premium
Ratings
VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut
4M ago
VNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >